Peer-influenced content. Sources you trust. No registration required. This is HCN.
Practical Neurology
Sanbexin’s sublingual formulation offers a potential paradigm shift in acute ischemic stroke treatment, enabling flexible administration outside traditional hospital settings.
Emergency Medicine September 25th 2024
The New England Journal of Medicine
Tenecteplase administered up to 24 hours after stroke onset improved functional outcomes in patients with large-vessel occlusion and salvageable brain tissue who lacked access to immediate thrombectomy.
Emergency Medicine July 30th 2024
In a Chinese study, tenecteplase administered 4.5 to 24 hours after stroke onset resulted in less disability at 90 days compared to standard treatment, though it carried a higher risk of symptomatic intracranial hemorrhage.
Neurology July 3rd 2024
In a randomized trial of 1,412 patients with acute ischemic stroke, reteplase was more likely to result in excellent functional outcomes at 90 days compared to alteplase.
Epoch Health
High levels of xylitol, a sugar substitute commonly used by diabetic patients, may increase the risk of heart attack and stroke, according to a Cleveland Clinic study.
Cardiology June 18th 2024
Prehospital management of blood pressure in patients with suspected acute stroke shows varying impacts depending on the stroke type. Immediate reduction improves outcomes in hemorrhagic stroke but may worsen outcomes in ischemic stroke, emphasizing the need for tailored approaches in early stroke care.
Cardiology June 4th 2024